NK

Nutan Kumari

Active Director Director DIN 09076248
DIN 09076248 First appointment Feb 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Nutan Kumari

Data last updated:

Nutan Kumari is a Director at Mvalsan Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Mvalsan Pharmaceuticals Private Limited reported revenue of ₹52,000 (FY 2022).

DIN 09076248
Primary Designation Director
Industry Chemicals
First Appointment 22 Feb 2021
Oldest Company Age 5 yrs
Largest company Mvalsan Pharmaceuticals Private Limited · ₹52,000 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Feb 20212021₹52,000 (FY 2022)Active

Board colleagues of Nutan Kumari

NameDINCompanyDesignation
Satish Kumar09076247Mvalsan Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mvalsan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nutan Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nutan Kumari

Nutan Kumari currently holds 1 directorship: Mvalsan Pharmaceuticals Private Limited (Director, since 22 Feb 2021, revenue ₹52,000 (FY 2022)).

Nutan Kumari was first appointed on 22 Feb 2021 as Director at Mvalsan Pharmaceuticals Private Limited.

The current boards of Nutan Kumari's companies include Satish Kumar (Mvalsan Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available